DOCSLIB.ORG

Meprin Α and Meprin Β: Procollagen Proteinases in Health and Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Meprin Α and Meprin Β: Procollagen Proteinases in Health and Disease Review Meprin α and meprin β: Procollagen proteinases in health and disease Johannes Prox a, Philipp Arnold b and Christoph Becker-Pauly a a - Unit for Degradomics of the Protease Web, Institute of Biochemistry, University of Kiel, Kiel, Germany b - Anatomical Institute, University of Kiel, Kiel, Germany Correspondence to Christoph Becker-Pauly: Unit for Degradomics of the Protease Web, Institute of Biochemistry, University of Kiel, 24229 Kiel, Germany. Tel.: +49 431 880 7118; fax: +49 431 880 5007. [email protected] kiel.de. http://dx.doi.org/10.1016/j.matbio.2015.01.010 Edited by W.C. Parks and S. Apte Abstract Metalloproteases meprin α and meprin β were recently discovered as procollagen proteinases, capable of cleaving off the globular C- and N-terminal prodomains of fibrillar collagen type I and type III. This proteolytic process is indeed sufficient to induce collagen fibril assembly as visualized by transmission electron microscopy. The biological relevance was demonstrated with the help of meprin α and meprin β knock-out mice, which exhibit decreased collagen deposition in skin resulting in impaired tensile strength. On the other hand, overexpression of meprin metalloproteases was found under fibrotic conditions in the skin (keloids) and the lung (pulmonary hypertension). Thus, regulation of meprin activity by specific inhibition to reduce collagen maturation might be a suitable approach for the treatment of certain pathological conditions. © 2015 Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/). Introduction [12,13]. This cleavage event at the so-called β-site enables γ-secretase to further cleave the remaining Meprin α and meprin β are multidomain metallopro- C-terminal fragment of APP within the membrane, teases with distinct functions during various physiolog- thereby releasing Aβ-peptides, which are known to be ical and pathophysiological conditions. They are involved in the onset and progression of Alzheimer's involved in inflammation by the release and maturation disease. Meprin β itself can be shed from the cell of cytokines [1,2] and proteoglycans [3], they induce surface by a disintegrin and metalloprotease 10 and 17 extracellular matrix assembly and fibrosis [4,5], and (ADAM10/17) [14]. As a soluble protein meprin β is no enhance cancer progression through trans-activation longer capable of cleaving APP at the β-site [12],thus of EGF receptors [6]. Several studies indicated that indicating a complex regulation of proteolytic activity by meprin α and meprin β may be reminiscent of matrix ectodomain shedding. Meprin α instead is constitutively metalloproteases (MMPs) “simply” degrading extracel- shed by furin during the secretory pathway and lular matrix (ECM) components, thereby promoting cell secreted into extracellular space [15]. Interestingly, migration and metastasis [7,8]. But meprins are much we and others could show that meprin α tends to more discriminating between substrates than expect- oligomerize to huge complexes up to the mega Dalton ed, which is reflected by defined cleavage specificity range, which makes it the largest extracellular protease and structural features unique among all proteases [9– [16,17] (See Fig. 1). These fascinating ring and chain 11]. For instance, meprin β is expressed as a dimeric like structures can easily be visualized by transmission type 1 transmembrane protein and acts as a sheddase electron microscopy (TEM), but structure-function at the cell surface where it releases the entire relationships are still ambiguous. Besides the different ectodomain of amyloid precursor protein (APP) cellular localization, meprin α and meprin β were found 0022-2836/© 2015 Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/). Matrix Biol. (2015) 44–46,7–13 8 Procollagen proteinases in health and disease Fig. 1. Activation, shedding and ECM substrates of meprin metalloproteases. Meprins are secreted as zymogens and are activated by trypsin-like serine proteases (e.g., human kallikrein related peptidases, KLK). Meprin β is intrinsically membrane bound and can be shed from the cell surface by ADAM10/17. Several components of the ECM have been described as meprin substrates. These include, for example, MMP1, which is inactivated by meprins, or nidogen and fibronectin, which were shown to be cleaved in vitro. For procollagen type 1 it was demonstrated that cleavage of the prodomain leads to spontaneous fibril formation. Meprin deficient mice show a reduced tensile strength pointing towards an important in vivo function in collagen deposition. Left box shows the domain structure of meprin α and meprin β. Both consist of a propeptide (PRO), a catalytic domain (CAT), a MAM (meprin A5 protein tyrosine phosphatase μ) domain, a TRAF (tumor-necrosis-factor-receptor-associated factor) domain, an EGF (epidermal growth factor) like domain, a transmem- brane region and a C-terminal part. Additionally, there is a so called inserted (I) domain found in meprin α between the TRAF and the EGF like domain. This inserted domain is cleaved by furin resulting in secretion into extracellular space. Meprin α forms large oligomers up to 6.4 MDa through a yet unknown oligomerisation site. This makes it the largest secreted protease known as depicted in the transmission electron microscopy image. to be differentially expressed in the small and large From proteomics to substrates intestine, leucocytes, and several tumors [18].In normal dermal skin, meprin α is constitutively higher In the last years several approaches were initiated expressed than meprin β, but both proteases are highly to characterize meprin metalloproteases in more up-regulated in keloid tissue [19]. detail in matters of substrate identification, specificity Recently, we demonstrated that meprin α and and structure [5,21]. Employing a mass spectro- meprin β are C- and N-procollagen proteinases metry-based proteomics technique called PICS thereby inducing collagen fibril assembly [4] (See (Proteomic Identification of Protease Cleavage Fig. 1). This biological activity is directly associated Sites) [22], we identified a unique cleavage site with increased expression of meprin metallopro- specificity for meprin α and meprin β with a pref- teases in fibrotic conditions [19,20]. These obser- erence for negatively charged amino acids (aspar- vations are summarized herein and provide tate and glutamate) particularly in the P1′ position evidence for important functions of meprin α and [10] (nomenclature by Schechter and Berger) [23]. meprin β in ECM homeostasis in health Terminal amine isotopic labeling of substrates and disease. (TAILS) [24], another proteomics approach, enabled Procollagen proteinases in health and disease 9 us to identify a multitude of specific meprin Thus compensatory mechanisms by other proteolytic substrates, among these proteases, cytokines, enzymes with regard to procollagen maturation, or extracellular matrix proteins, growth factors and other BMP-1-associated activities, such as myostatin adhesion molecules [14]. However, the biological activation, are needed in different organs. Metallo- roles of meprin α and meprin β with regard to their proteases ADAMTS-2, 3, and 14 were shown to substrates, inhibitors, or other regulatory proteins as release the N-propeptides of fibrillar collagens [35] part of the protease web have to be further (review by Bekhouche and Colige). However, as investigated. shown for BMP-1, ADAMTS-2, 3, and 14 deficient Meprin knockout mice as loss of function models cells exhibited remaining N-procollagen proteinase are viable, fertile and do not show a striking devel- activity, indicating the existence of other compensat- opmental phenotype despite the broad substrate ing proteolytic enzymes [36,37]. spectrum identified [25,26]. Initial studies of Employing the proteomics based approach TAILS, meprins in the intestine and kidney of mice, we identified human procollagen type I as a sub- where these proteases are found to be highly strate of meprin α and meprin β [14]. Incubation of expressed, revealed that meprin α and meprin β purified recombinant procollagen I with meprin α and are somehow involved in pro- and/or anti-inflam- meprin β and subsequent analysis by western matory processes (LPS-sepsis-, colitis-models) but blotting identified both meprins as C-and N-procolla- the detailed molecular pathways initiated or regu- gen proteinases [4] (See Fig. 1). Moreover it was lated by meprins remain elusive [2,27]. Except of shown that incubation of procollagen I with meprin α the few inflammatory models the roles of meprins or meprin β led to spontaneous fibril formation that during challenged or pathological conditions in can be observed using transmission electron mi- mice have not been investigated in detail yet. croscopy (TEM). Full maturation of procollagen I by However, under unchallenged conditions defects in single enzymes as observed with meprins is in collagen assembly in skin could be identified due to contrast to the previously described procolla- alterations in N- and C-propeptide processing of genases BMP-1, tolloid1/2, and ADAMTS-2, 3, and collagen I in the dermis of meprin α and meprin β 14 [31,35]. As BMP-1 cleaves off only the C-terminal deficient mice [4]. and ADAMTS proteases only the N-terminal propep- tides of procollagen I this is not sufficient for spontaneous fibril formation as demonstrated by Meprins in collagen maturation
Load more

Recommended publications
  • Discovery and Optimization of Selective Inhibitors of Meprin Α (Part II)
    pharmaceuticals Article Discovery and Optimization of Selective Inhibitors of Meprin α (Part II) Chao Wang 1,2, Juan Diez 3, Hajeung Park 1, Christoph Becker-Pauly 4 , Gregg B. Fields 5 , Timothy P. Spicer 1,6, Louis D. Scampavia 1,6, Dmitriy Minond 2,7 and Thomas D. Bannister 1,2,* 1 Department of Molecular Medicine, Scripps Research, Jupiter, FL 33458, USA; [email protected] (C.W.); [email protected] (H.P.); [email protected] (T.P.S.); [email protected] (L.D.S.) 2 Department of Chemistry, Scripps Research, Jupiter, FL 33458, USA; [email protected] 3 Rumbaugh-Goodwin Institute for Cancer Research, Nova Southeastern University, 3321 College Avenue, CCR r.605, Fort Lauderdale, FL 33314, USA; [email protected] 4 The Scripps Research Molecular Screening Center, Scripps Research, Jupiter, FL 33458, USA; [email protected] 5 Unit for Degradomics of the Protease Web, Institute of Biochemistry, University of Kiel, Rudolf-Höber-Str.1, 24118 Kiel, Germany; fi[email protected] 6 Department of Chemistry & Biochemistry and I-HEALTH, Florida Atlantic University, 5353 Parkside Drive, Jupiter, FL 33458, USA 7 Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, 3301 College Avenue, Fort Lauderdale, FL 33314, USA * Correspondence: [email protected] Abstract: Meprin α is a zinc metalloproteinase (metzincin) that has been implicated in multiple diseases, including fibrosis and cancers. It has proven difficult to find small molecules that are capable Citation: Wang, C.; Diez, J.; Park, H.; of selectively inhibiting meprin α, or its close relative meprin β, over numerous other metzincins Becker-Pauly, C.; Fields, G.B.; Spicer, which, if inhibited, would elicit unwanted effects.
    [Show full text]
  • Structural Basis for the Sheddase Function of Human Meprin Β Metalloproteinase at the Plasma Membrane
    Structural basis for the sheddase function of human meprin β metalloproteinase at the plasma membrane Joan L. Arolasa, Claudia Broderb, Tamara Jeffersonb, Tibisay Guevaraa, Erwin E. Sterchic, Wolfram Boded, Walter Stöckere, Christoph Becker-Paulyb, and F. Xavier Gomis-Rütha,1 aProteolysis Laboratory, Department of Structural Biology, Molecular Biology Institute of Barcelona, Consejo Superior de Investigaciones Cientificas, Barcelona Science Park, E-08028 Barcelona, Spain; bInstitute of Biochemistry, Unit for Degradomics of the Protease Web, University of Kiel, D-24118 Kiel, Germany; cInstitute of Biochemistry and Molecular Medicine, University of Berne, CH-3012 Berne, Switzerland; dArbeitsgruppe Proteinaseforschung, Max-Planck-Institute für Biochemie, D-82152 Planegg-Martinsried, Germany; and eInstitute of Zoology, Cell and Matrix Biology, Johannes Gutenberg-University, D-55128 Mainz, Germany Edited by Brian W. Matthews, University of Oregon, Eugene, OR, and approved August 22, 2012 (received for review June 29, 2012) Ectodomain shedding at the cell surface is a major mechanism to proteolysis” step within the membrane (1). This is the case for the regulate the extracellular and circulatory concentration or the processing of Notch ligand Delta1 and of APP, both carried out by activities of signaling proteins at the plasma membrane. Human γ-secretase after action of an α/β-secretase (11), and for signal- meprin β is a 145-kDa disulfide-linked homodimeric multidomain peptide peptidase, which removes remnants of the secretory pro- type-I membrane metallopeptidase that sheds membrane-bound tein translocation from the endoplasmic membrane (13). cytokines and growth factors, thereby contributing to inflammatory Recently, human meprin β (Mβ) was found to specifically pro- diseases, angiogenesis, and tumor progression.
    [Show full text]
  • Metalloproteases Meprin Α and Meprin Β Are C- and N-Procollagen Proteinases Important for Collagen Assembly and Tensile Strength
    Metalloproteases meprin α and meprin β are C- and N-procollagen proteinases important for collagen assembly and tensile strength Claudia Brodera, Philipp Arnoldb, Sandrine Vadon-Le Goffc, Moritz A. Konerdingd, Kerstin Bahrd, Stefan Müllere, Christopher M. Overallf, Judith S. Bondg, Tomas Koudelkah, Andreas Tholeyh, David J. S. Hulmesc, Catherine Moalic, and Christoph Becker-Paulya,1 aUnit for Degradomics of the Protease Web, Institute of Biochemistry, University of Kiel, 24118 Kiel, Germany; bInstitute of Zoology, Johannes Gutenberg University, 55128 Mainz, Germany; cTissue Biology and Therapeutic Engineering Unit, Centre National de la Recherche Scientifique/University of Lyon, Unité Mixte de Recherche 5305, Unité Mixte de Service 3444 Biosciences Gerland-Lyon Sud, 69367 Lyon Cedex 7, France; dInstitute of Functional and Clinical Anatomy, University Medical Center, Johannes Gutenberg University, 55128 Mainz, Germany; eDepartment of Gastroenterology, University of Bern, CH-3010 Bern, Switzerland; fCentre for Blood Research, University of British Columbia, Vancouver, BC, Canada V6T 1Z3; gDepartment of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA 17033; and hInstitute of Experimental Medicine, University of Kiel, 24118 Kiel, Germany Edited by Robert Huber, Max Planck Institute of Biochemistry, Planegg-Martinsried, Germany, and approved July 9, 2013 (received for review March 22, 2013) Type I fibrillar collagen is the most abundant protein in the human formation (22). A tight balance between synthesis and break- body, crucial for the formation and strength of bones, skin, and down of ECM is required for the function of all tissues, and tendon. Proteolytic enzymes are essential for initiation of the dysregulation leads to pathophysiological events, such as arthri- assembly of collagen fibrils by cleaving off the propeptides.
    [Show full text]
  • On and Polymorphisms in Q Fever
    Matrix metalloproteinase expression, produc3on and polymorphisms in Q fever Anne F.M. Jansen1,2, Teske Schoffelen1,2, Julien Textoris3, Jean Louis Mege3, Chantal P. Bleeker-Rovers1,2, Esther van de Vosse4, Hendrik Jan Roest5, Marcel van Deuren1,2 1. Department of Internal Medicine, Division of Experimental Medicine, Radboud university medical center, Nijmegen, The Netherlands 2. Radboud Expert Centre for Q fever, Radboud university medical center, Nijmegen, the Netherlands, 3. URMITE, CNRS UMR 7278, IRD 198, INSERM 1095 Aix-Marseille University, Marseille, France 4. Department of Infec3ous Diseases, Leiden University Medical Center, Leiden, The Netherlands 5. Department of Bacteriology and TSEs, Central Veterinary Instute, part of Wageningen UR, Lelystad, the Netherlands Background C. burnei induces MMP-1 and MMP-9 produc3on in PBMCs Chronic Q fever is a life threatening condi3on caused by the Gram-negave bacterium Coxiella burnei, manifes3ng as an infec3on of aneurysms, aor3c prosthesis or heart valves. Matrix metalloproteinases (MMPs) are proteoly3c enzymes that cleave extracellular matrix and are implicated in the pathology of aneurysms and endocardi3s. Currently, the contribu3on of MMPs to the pathogenesis of chronic Q fever is unknown. Methods We inves3gated the C. burnei specific gene expression of MMPs in PBMCs and protein produc3on by ELISA in chronic Q fever paents (n=6, n=10, respec3vely), cardiovascular paents with a history of Q fever (n=10) and healthy controls (n=4, n=10, respec3vely), in some experiments, the controls had vascular disease (n=10). Circulang MMP levels were assessed with Luminex technology and these groups were also genotyped for 20 SNPs in MMP and Tissue Inhibitor of MMP (TIMP) genes.
    [Show full text]
  • Prognostic Significance of MMP-1 and MMP-3 Functional Promoter Polymorphisms in Colorectal Cancer
    594 Vol. 11, 594–599, January 15, 2005 Clinical Cancer Research Prognostic Significance of MMP-1 and MMP-3 Functional Promoter Polymorphisms in Colorectal Cancer Franck Zinzindohoue´,1 Thierry Lecomte,2 INTRODUCTION Jean-Marc Ferraz,2 Anne-Marie Houllier,1 Matrix metalloproteinase (MMP) belongs to a large group Paul-Henri Cugnenc,2 Anne Berger,2 of proteases, which includes over 22 known human zinc- He´le`ne Blons,1 and Pierre Laurent-Puig1 dependent proteolytic enzymes. These are capable of breaking essentially all components of the extracellular matrix (1, 2). 1INSERM U490 Laboratoire de toxicologie Mole´culaire and 2 MMPs take part in high tissue turnover and remodeling, both Poˆle de cance´rologie Hoˆpital europe´en Georges Pompidou, Paris, France physiologic and pathologic conditions such as cancer. MMPs are also implicated in all steps of tumorogenesis, cancer invasion, and metastasis (3). Tumor invasion and metastasis formation ABSTRACT always begin with blood and lymphatic vessel infiltration. As Purpose: Matrix metalloproteinase (MMP) belongs to a these processes involve proteolysis of the extracellular matrix, large group of proteases capable of breaking essentially all MMPs are suggested to play a major role in tumor progression. components of the extracellular matrix. They are implicated Colorectal cancer is the most common malignancy of the in all steps of tumorogenesis, cancer invasion, and gastrointestinal tract. It is the third cause of cancer overall and metastasis. Among them, metalloproteinase type 1 (MMP- the second leading cause of cancer-related death in the Europe 1) is implicated in tumor invasion and metastasis in and the United States with an incidence of 300,000 new cases different types of cancers including colorectal cancer in (4).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown Et Al
    US 20030082511A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown et al. (43) Pub. Date: May 1, 2003 (54) IDENTIFICATION OF MODULATORY Publication Classification MOLECULES USING INDUCIBLE PROMOTERS (51) Int. Cl." ............................... C12O 1/00; C12O 1/68 (52) U.S. Cl. ..................................................... 435/4; 435/6 (76) Inventors: Steven J. Brown, San Diego, CA (US); Damien J. Dunnington, San Diego, CA (US); Imran Clark, San Diego, CA (57) ABSTRACT (US) Correspondence Address: Methods for identifying an ion channel modulator, a target David B. Waller & Associates membrane receptor modulator molecule, and other modula 5677 Oberlin Drive tory molecules are disclosed, as well as cells and vectors for Suit 214 use in those methods. A polynucleotide encoding target is San Diego, CA 92121 (US) provided in a cell under control of an inducible promoter, and candidate modulatory molecules are contacted with the (21) Appl. No.: 09/965,201 cell after induction of the promoter to ascertain whether a change in a measurable physiological parameter occurs as a (22) Filed: Sep. 25, 2001 result of the candidate modulatory molecule. Patent Application Publication May 1, 2003 Sheet 1 of 8 US 2003/0082511 A1 KCNC1 cDNA F.G. 1 Patent Application Publication May 1, 2003 Sheet 2 of 8 US 2003/0082511 A1 49 - -9 G C EH H EH N t R M h so as se W M M MP N FIG.2 Patent Application Publication May 1, 2003 Sheet 3 of 8 US 2003/0082511 A1 FG. 3 Patent Application Publication May 1, 2003 Sheet 4 of 8 US 2003/0082511 A1 KCNC1 ITREXCHO KC 150 mM KC 2000000 so 100 mM induced Uninduced Steady state O 100 200 300 400 500 600 700 Time (seconds) FIG.
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant
    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
    [Show full text]
  • Role of MMP-1, MMP-8 and MMP-9 Gene Polymorphisms in Preterm Birth
    Journal of Genetics (2020)99:2 Ó Indian Academy of Sciences https://doi.org/10.1007/s12041-019-1161-7 (0123456789().,-volV)(0123456789().,-volV) RESEARCH ARTICLE Role of MMP-1, MMP-8 and MMP-9 gene polymorphisms in preterm birth MONIKA PANDEY* and SHALLY AWASTHI Department of Pediatrics, King George’s Medical University, Lucknow 226 003, India *For correspondence. E-mail: [email protected]. Received 6 January 2019; revised 17 August 2019; accepted 18 September 2019 Abstract. Novel approaches to preterm births are underway building upon our prior discoveries and probing into unknown discovery pathways. The recent findings showed a high affinity of MMP-9 in serum and its polymorphisms for preterm birth. This study, which is a hospital-based case– control study, aims to investigate the association of MMP-1, MMP-8 and MMP-9 polymorphisms, and levels of MMP-9 in preterm birth. Increased level of MMP-9 was reported in cases as compared to control. The significant association of MMP-9 (-1562) CT (P=0.001; OR = 1.44 (CI = 0.97–2.14)) and TT genotype (P=0.05; OR = 2.6 (CI = 1.46–4.69)) were reported in preterm birth. Our findings suggest that the MMP-9 plays an important role in contributing preterm labour and this can be used as a diagnostic tool during pregnancy. Keywords. infection; inflammation; matrix metalloproteinases; polymorphism; preterm birth. Introduction altered gene expression may be an attributing factor of causing preterm birth (Sheikh et al. 2016). The functional polymorphisms Preterm birth (PTB) is the most prevailing and persistent situated in MMP-1, MMP-8 and MMP-9 promoter region may be problem causing enormous morbidity and mortality among a contributing element (Fanjul-Ferna´ndez et al.
    [Show full text]
  • A Therapeutic Role for MMP Inhibitors in Lung Diseases?
    ERJ Express. Published on June 9, 2011 as doi: 10.1183/09031936.00027411 A therapeutic role for MMP inhibitors in lung diseases? Roosmarijn E. Vandenbroucke1,2, Eline Dejonckheere1,2 and Claude Libert1,2,* 1Department for Molecular Biomedical Research, VIB, Ghent, Belgium 2Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium *Corresponding author. Mailing address: DBMR, VIB & Ghent University Technologiepark 927 B-9052 Ghent (Zwijnaarde) Belgium Phone: +32-9-3313700 Fax: +32-9-3313609 E-mail: [email protected] 1 Copyright 2011 by the European Respiratory Society. A therapeutic role for MMP inhibitors in lung diseases? Abstract Disruption of the balance between matrix metalloproteinases and their endogenous inhibitors is considered a key event in the development of pulmonary diseases such as chronic obstructive pulmonary disease, asthma, interstitial lung diseases and lung cancer. This imbalance often results in elevated net MMP activity, making MMP inhibition an attractive therapeutic strategy. Although promising results have been obtained, the lack of selective MMP inhibitors together with the limited knowledge about the exact functions of a particular MMP hampers the clinical application. This review discusses the involvement of different MMPs in lung disorders and future opportunities and limitations of therapeutic MMP inhibition. 1. Introduction The family of matrix metalloproteinases (MMPs) is a protein family of zinc dependent endopeptidases. They can be classified into subgroups based on structure (Figure 1), subcellular location and/or function [1, 2]. Although it was originally believed that they are mainly involved in extracellular matrix (ECM) cleavage, MMPs have a much wider substrate repertoire, and their specific processing of bioactive molecules is their most important in vivo role [3, 4].
    [Show full text]
  • Differential Regulation of Metzincins in Experimental Chronic Renal Allograft
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector original article http://www.kidney-international.org & 2006 International Society of Nephrology Differential regulation of metzincins in experimental chronic renal allograft rejection: Potential markers and novel therapeutic targets CC Berthier1,2,8, N Lods1,8, SA Joosten3, C van Kooten3, D Leppert4, RLP Lindberg4, A Kappeler5, F Raulf6, EE Sterchi7, D Lottaz7 and H-P Marti1 1Division of Nephrology/Hypertension, Inselspital, University of Bern, Bern, Switzerland; 2Division of Nephrology, University Hospital of Zu¨rich, Zu¨rich, Switzerland; 3Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands; 4Department of Neurology, University of Basel, Basel, Switzerland; 5Institute of Pathology, University of Bern, Bern, Switzerland; 6Department of Transplantation, Novartis Institutes of BioMedical Research, Basel, Switzerland and 7Institute of Biochemistry and Molecular Biology, University of Bern, Bern, Switzerland Chronic renal allograft rejection is characterized by chronic renal allograft rejection. Thus, an altered pattern of alterations in the extracellular matrix compartment and in metzincins may represent novel diagnostic markers and the proliferation of various cell types. These features are possibly may provide novel targets for future therapeutic controlled, in part by the metzincin superfamily of interventions. metallo-endopeptidases, including matrix metalloproteinases Kidney International
    [Show full text]
  • MEP1A Allele for Meprin a Metalloprotease Is a Susceptibility Gene for Inflammatory Bowel Disease
    ARTICLES nature publishing group See COMMENTARY page XX MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease S B a n e r j e e 1 , 8 , B O n e d a 2 , 8 , L M Ya p 3 , 9 , D P J e w e l l 4 , G L M a t t e r s 1 , L R F it5 z p a , t r ic k F 6 S e , ib o l dE E 2 , S t e r c h i T A h m a d 7 , D L o t t a z 2,10 a n d J S B o n d 1 The MEP1A gene, located on human chromosome 6p (mouse chromosome 17) in a susceptibility region for inflammatory bowel disease (IBD), encodes the -subunit of metalloproteinase meprin A, which is expressed in the intestinal epithelium. This study shows a genetic association of MEP1A with IBD in a cohort of ulcerative colitis (UC) patients. There were four single-nucleotide polymorphisms in the coding region (P = 0.0012 – 0.04), and one in the 3 Ј -untranslated region ( P = 2 × 10 − 7 ) that displayed associations with UC. Moreover, meprin- mRNA was decreased in inflamed mucosa of IBD patients. Meprin- knockout mice exhibited a more severe intestinal injury and inflammation than their wild-type counterparts following oral administration of dextran sulfate sodium. Collectively, the data implicate MEP1A as a UC susceptibility gene and indicate that decreased meprin- expression is associated with intestinal inflammation in IBD patients and in a mouse experimental model of IBD.
    [Show full text]